Share Article

According to court documents, on December 6th, 2012, a Texas resident and his wife filed a lawsuit in Pennsylvania Eastern District Court alleging he developed prostate cancer from his use of the drug Avodart. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Avodart side effects.

Avodart: severe adverse events

(including Avodart) may increase the risk of development of high-grade prostate cancer

Past News Releases

AttorneyOne.com, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Avodart lawsuits.

According to court documents, on December 6th, 2012, a Texas resident and his wife filed an Avodart Lawsuit in Pennsylvania Eastern District Court (case no. 2:2012cv06818) alleging he developed prostate cancer from his use of the drug Avodart. Avodart (dutasteride), manufactured by GlaxoSmithKline, was approved by the FDA in October 2002 to treat the symptoms of an enlarged prostate gland (benign prostatic hyperplasia or BPH). It is also approved to reduce the risk of urinary retention or surgery related to an enlarged prostate.

Avodart belongs to a class of drugs known as 5-alpha reductase inhibitors (5-ARI). In June 2011, the US FDA issued a warning that 5 alpha-reductase inhibitors (including Avodart) may increase the risk of development of high-grade prostate cancer. And in June 2012, the FDA informed “prior to initiating treatment with Avodart, consideration should be given to other urological conditions that may cause similar symptoms. In addition, BPH and prostate cancer may coexist.”

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Avodart severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Avodart lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On March 19th, 2012 Health Canada issued a warning that Avodart, and other drugs used to treat enlarged prostate, may be associated with an increased risk of developing a serious form of prostate cancer known as high-grade prostate cancer.

AttorneyOne.com has further information on Avodart lawsuits including how to get in contact with legal counsel.